Since February 2018, Claus Runge led the Global Market Access group, as of July 2019, the Global Market
Access, Public Affairs & Sustainability Group and as of June 2024, he is leading the Public Affairs,
Sustainability & Internal Engagement Group at Bayer AG – Division Pharmaceuticals, and acts as its Chief
Health Equity Officer.
Claus Runge has twenty-six years of experience in working in the pharmaceutical industry. He has held
senior roles on both local and global level in various multinational companies, such as GSK, Wyeth and
AstraZeneca. In his career, he has been responsible for a broad span of functions, including Commercial,
Pricing & Market Access, Communications, Governmental Affairs as well as Patient Advocacy. Claus also
is Bayer representative/member of the IFPMA Council, the IFMPA-AMR and the PhRMA Heads of
International Committee. Additionally, he will also join the Executive Council of the Bill & Melinda Gates
CEO RT.
Claus Runge is a pharmacist and health economist by training and holds a Ph.D. from the Humboldt
University in Berlin. He served as one of the editors of the European Journal of Health Economics from
2006-201, helping it to become a renowned journal in the field. He has published numerous articles in
high impact journals, with a focus on health economics and quality of life research. Since 2022, he serves
as a board member of the “Technologie Stiftung Berlin”.